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Introduction 
 
The vast majority of what we understand about calcium (Ca) homeostasis during 
the transition period was originally discovered by Dr. Ronald L. Horst (1949-2019) and 
his students/collaborators at the USDA National Animal Disease Center in Ames, IA. At 
lactation onset, dairy cows experience a marked increase (>65%; DeGaris and Lean, 
2008) in Ca requirements to support colostrum and milk synthesis (Horst et al., 2005). 
The dairy industry has long hypothesized that the mammary gland’s Ca demand is so 
extensive and acute that it often exceeds the homeostatic mechanisms (i.e., parathyroid 
hormone [PTH] and Vitamin D) employed to replenish it and as a result clinical or 
subclinical hypocalcemia (SCH) occurs (Horst et al., 2005; Goff, 2008). Implementing 
therapeutic and prophylactic strategies (i.e., pre-calving acidifying rations) has markedly 
reduced the incidence of clinical hypocalcemia (Charbonneau et al., 2006; Reinhardt et 
al., 2011), but SCH remains common. Some consider post-calving SCH as “pathological” 
and assume it causal in a myriad of seemingly unrelated negative health outcomes 
(ketosis, poor reproduction, displaced abomasum [DA], immune suppression, etc.; 
Caixeta et al., 2017; Rodríguez et al., 2017; Neves et al., 2018a,b). We suggest (outlined 
below) that periparturient immune activation contributes to clinical and SCH and the low 
circulating Ca is a consequence (a reflection) of inflammation rather than a predictor of 
future problems.  In fact, we hypothesize that many post-calving undesirable phenotypes 
(reduced dry matter intake [DMI], hypocalcemia, elevated non-esterified fatty acids 
[NEFA], hyperketonemia) are a consequence of immune activation and not themselves 
causative of transition cow maladies. 
 
Subclinical Hypocalcemia 
 
 Subclinical hypocalcemia remains a prevalent metabolic disorder afflicting ~25% 
of primiparous and ~50% of multiparous cows in the United States (Reinhardt et al., 
2011). Although no overt symptoms accompany SCH, it has been loosely associated with 
poor gut motility, increased risk of DA, reduced production performance (i.e., milk yield 
and feed intake), increased susceptibility to infectious disease, impaired reproduction, 
and an overall higher culling risk (Curtis et al., 1983; Hansen et al., 2003; Seifi et al., 
2011; Oetzel and Miller, 2012; Caixeta et al., 2017). Recent reports indicate that the 
severity of negative health outcomes observed in SCH cows appears dependent on the 
magnitude, persistency, and timing of SCH (Caixeta et al., 2017; McArt and Neves, 2019). 
For example, Caixeta et al. (2017) classified cases as either SCH or chronic SCH and 
observed more pronounced impairments on reproductive performance with chronic SCH. 
Similarly, McArt and Neves (2019) classified cows into 1 or 4 groups based on post-
calving Ca concentrations: normocalcemia (>2.15 mmol/L at 1 and 2 DIM), transient SCH 
(≤ 2.15 mmol/L at 1 DIM), persistent SCH (≤ 2.15 mmol/L at 1 and 2 DIM), or delayed 
SCH (> 2.15 mmol/L at 1 DIM and ≤ 2.15 mmol/L at 2 DIM). Cows experiencing transient 
SCH produced more milk and were no more likely to experience a negative health event 
when compared to normocalcemic cows, whereas the opposite (i.e., higher health risk 
and hindered productivity) was observed in cows experiencing either persistent or 
delayed SCH. Clearly not all cases of SCH are equivalent; in fact, transient hypocalcemia 
appears to be correlated with improved “health” and productivity and this may explain why 
inconsistencies exist in the relationship between SCH and reduced productivity and 
health (Martinez et al., 2012; Jawor et al., 2012; Gidd et al., 2015). However, it remains 
unclear why despite successful implementation of mitigation strategies, SCH remains 
prevalent, why SCH is associated with a myriad of seemingly unrelated disorders, and 
what underlying factors may be explaining the different “types” of SCH. 
 
In addition to SCH, there are on-farm milk-fever situations that are biologically 
difficult to explain.  For example, even while strictly adhering to a pre-calving calcium 
strategy, there remains a small percentage (~<1%) of cows that develop clinical 
hypocalcemia.  Additionally, reasons for why a mid-lactation cow develops milk-fever are 
not obvious.  Further, there appears to be an undecipherable seasonality component to 
clinical hypocalcemia in the southwest and western USA that coincides with the rainy 
season.  Inarguably, there remain some aspects of Ca homeostasis that continue to 
evade discovery. 
 
Inflammation in the Transition Period 
 
Regardless of health status (Humblet et al., 2006), increased inflammatory 
biomarkers are observed in nearly all cows during the periparturient period (Ametaj et al., 
2005; Humblet et al., 2006 Bionaz et al., 2007; Bertoni et al., 2008;; Mullins et al., 2012). 
The magnitude and persistency of the inflammatory response seems to be predictive of 
transition cow performance (Bertoni et al., 2008; Bradford et al., 2015; Trevisi and Minuti, 
2018). During the weeks surrounding calving, cows are exposed to a myriad of stressors 
which may permit endotoxin entry into systemic circulation and thereby initiate an 
inflammatory response (Khafipour et al., 2009; Kvidera et al., 2017a; Proudfoot et al., 
2018; Barragan et al., 2018; Koch et al., 2019). The frequency and severity of these 
inflammation-inducing insults presumably determines the level of inflammation that 
follows (Bertoni et al., 2008; Trevisi and Minuti, 2018). Common origins of endotoxin entry 
include the uterus (metritis) and mammary gland (mastitis). Additionally, we believe the 
gastrointestinal tract may contribute as many of the characteristic responses (rumen 
acidosis, decreased feed intake, and psychological stress) occurring during the transition 
period can compromise gut barrier function (see companion paper by Horst and 
Baumgard).  
 
Although an overt inflammatory response is present around calving, numerous 
reports have described a reduction in immune competence during this time (Kehrli et al., 
1989; Goff and Horst, 1997; Lacetera et al., 2005). Traditionally, hypocalcemia has been 
one of the primary factors considered responsible for periparturient immunosuppression 
(Horst, 1997; Kimura et al., 2006), however, recent evidence suggests that the systemic 
inflammatory milieu may be mediating these effects (Heyland et al., 2006; Trevisi and 
Minuti, 2018). Furthermore, it was recently proposed that the immune system was not 
necessarily “suppressed,” but merely dysregulated around calving (Trevisi and Minuti, 
2018). Whether or not the immune incompetence frequently reported post-calving (Kehrli 
et al., 1989; Goff and Horst, 1997; Lacetera et al., 2005) is causative to future illnesses 
or is a consequence of prior immune stimulation needs further attention. 
 
Inflammation and Metabolic Disorders 
 
 The periparturient period is associated with substantial metabolic changes 
involving normal homeorhetic adaptions to support milk production. Early lactation dairy 
cows enter a normal physiological state during which they are unable to consume enough 
nutrients to meet maintenance and milk production costs and typically enter into negative 
energy balance (NEB; Drackley, 1999; Baumgard et al., 2017). During NEB, cows 
mobilize NEFA in order to partition glucose for milk production in a homeorhetic strategy 
known as the “glucose sparing”. Excessive NEFA mobilization and the affiliated increase 
in hepatic lipid uptake, triglyceride (TG) storage, and ketone body production has been 
traditionally believed to be the driving factor leading to ketosis and fatty liver (Grummer, 
1993; Drackley, 1999). Until recently, this dogma has been well-accepted as ruminants 
are thought to have a poor capacity to export TG as very low density lipoproteins (Emery 
et al., 1992). However, increasing evidence suggests that chronic inflammation may be 
the driver of these disorders (Bertoni et al., 2006; Eckel and Ametaj, 2016) and this is 
supported by human, rodent, and ruminant literature which demonstrate effects of 
lipopolysaccharide (LPS) and inflammatory mediators on metabolism and hepatic lipid 
accumulation (Li et al., 2003; Barbuio et al., 2007; Endo et al., 2007; Bradford et al., 2009; 
Ilan et al., 2012; Ceccarelli et al., 2015). We and others have demonstrated that cows 
which develop ketosis and fatty liver postpartum had higher concentrations of LPS and 
acute phase proteins prior to diagnosis (Ohtsuka et al., 2001; Ametaj et al., 2005; 
Abuajamieh et al., 2016). Aside from the mechanistic changes on hepatic function, 
immune activation markedly reduces DMI (highly conserved response across species) 
which further increases NEFA mobilization and hepatic ketogenesis. Additional 
investigation is still needed to better elucidate the mechanisms by which LPS alters 
hepatic lipid handling and ketone synthesis and extra-hepatic ketone utilization. 
 
Inflammation and Reproductive Function 
 
 Bacteria are ubiquitous within the postpartum uterus and pathogenic strains often 
persist leading to immune activation and consequently infertility (Sheldon and Dobson, 
2004; Sheldon et al., 2019). Uterine infection has a variety of negative impacts on 
reproductive function including; a prolonged luteal phase (Peter and Bosu, 1988; Williams 
et al., 2008; Sheldon et al., 2009), disrupted ovarian steroidogenesis (Sheldon et al., 
2009), and abnormal or delayed folliculogenesis after parturition (Huszenicza et al., 
1999). Impaired reproductive functions are not isolated to infections which originate within 
the uterus. Mastitis, one of the most prevalent transition cow infections, disrupts follicular 
steroid concentrations and hinders oocyte maturation (Lavon et al., 2011; Asaf et al., 
2014). Furthermore, cows diagnosed with clinical mastitis prior to first service have an 
increased number of days to first service and days open (Barker et al., 1998).  
Administering LPS intravenously results in marked disruptions in hypothalamic and 
pituitary hormone release and ovarian responsiveness (Coleman et al., 1993; Battaglia 
et al., 2000) and induces abortion (Giri et al., 1990). Presumably, regardless of the origin, 
infection negatively influences immediate and future reproductive performance.  The 
direct effects of endotoxin and inflammation on reproduction likely explain the associated 
effects that NEFA, ketones and calcium have with fertility (because immune activation 
also directly affects these metabolites; as described below).    
 
Inflammation and Hypocalcemia  
 
Impressively, immune activation was originally hypothesized by early investigators 
to be involved with milk-fever (Thomas, 1889; Hibbs, 1950), but until recently (Eckel and 
Ametaj, 2016) it has rarely been considered a contributing factor to hypocalcemia. 
Independent of the transition period, we and others have repeatedly observed a marked 
and unexplainable decrease in circulating calcium following LPS administration in 
lactating cows (Griel et al., 1975; Waldron et al., 2003; Kvidera et al., 2017b; Al-Qaisi et 
al., 2017; Horst et al., 2018a,b, 2019). Infection-induced hypocalcemia is a species 
conserved response occurring in humans (Cardenas-Rivero et al., 1989; Dias et al., 
2013), calves (Tennant et al., 1973; Elsasser et al., 1996;), dogs (Holowaychuk et al., 
2012), horses (Toribio et al., 2008), pigs (Carlstedt et al., 2000) and sheep (Naylor and 
Kronfeld, 1986). Additionally, hypocalcemia occurs in response to ruminal acidosis in 
dairy cows (Minuti et al., 2014). It is unlikely that cows (even those that are presumably 
“healthy”) complete the transition period without experiencing at least one immune 
stimulating event and we are likely underestimating its contribution to postpartum 
hypocalcemia. 
 
Traditional Dogmas 
 
 Long-standing tenets describe a causal role of hypocalcemia, increased NEFA, 
and hyperketonemia in the incidence of transition diseases and disorders (Figure 1). 
Hypocalcemia has traditionally been considered a gateway disorder leading to ketosis, 
mastitis, metritis, displaced abomasum, impaired reproduction, and decreased milk yield 
(Curtis et al., 1983; DeGaris and Lean, 2008; Goff, 2008; Martinez et al., 2012; Chapinal 
et al., 2012; Riberio et al., 2013; Neves et al., 2018a,b). The proposed mechanisms by 
which hypocalcemia leads to these ailments include impaired skeletal muscle strength 
and gastrointestinal motility (Goff, 2008; Oetzel, 2013; Miltenburg et al., 2016), decreased 
insulin secretion (Martinez et al., 2012, 2014), and the development of 
immunosuppression (Kimura et al., 2006). Similar to hypocalcemia, increased NEFA and 
hyperketonemia are presumed causative to illnesses such as DA, retained placenta, 
metritis, reduced lactation performance, poor reproduction, and an overall increased 
culling risk (Cameron et al., 1998; LeBlanc et al., 2005; Duffield et al., 2005; Quiroz-Rocha 
et al., 2009; Ospina et al., 2010; Chapinal et al., 2011; Huzzey et al., 2011). Additionally, 
elevated NEFA and ketones are thought to compromise immune function (Lacetera et al., 
2004; Hammon et al., 2006; Scalia et al., 2006; Ster et al., 2012) and suppress feed intake 
(Allen et al., 2009).  Thus, the magnitude of changes in NEFA, BHB and Ca have 
traditionally thought to be predictors of future performance and problems. 
 
 
 
Figure 1. Traditional mechanisms by which hypocalcemia and increased NEFA and 
ketones are thought to cause poor transition cow health and performance. 
 
Immune Activation: The Etiological Origin 
 
 Strong evidence has been generated connecting immune activation as the 
etiological origin of many of the metabolic and reproductive disorders traditionally 
observed within the transition period. Additionally, it is probable that immune activation is 
at least partially explaining the incidence of SCH in the postpartum period (Figure 2). It is 
intriguing to suggest that cases of delayed, persistent, and chronic SCH recently 
described by Caixeta et al. (2017) and McArt and Neves (2019) may be related to the 
severity of the periparturient inflammatory response. This hypothesis may explain why 
these cases of SCH are associated with reduced “health”, as these represent direct 
consequences of immune activation rather than being related or caused by decreased 
Ca. Regardless, these reports challenge the traditional dogmas surrounding 
hypocalcemia, elevated NEFA, and hyperketonemia and the sequence of transition cow 
disease.  
 
 
 
Figure 2. Potential downstream consequences of immune activation.  In this model, 
decreased feed intake, hypocalcemia, excessive NEFA, hyperketonemia and 
hepatic lipidosis are not causative to poor transition cow performance and 
health, but rather a reflection of prior immune stimulation.   
 
Calcium Administration following Immunoactivation 
 
 Although LPS-induced hypocalcemia is a commonly observed phenomenon, it 
remains poorly understood what role Ca plays in inflammation and why it acutely 
decreases. Recently, we investigated the effects of oral and i.v. Ca administration 
following an LPS challenge in lactating dairy cows (Al-Qaisi et al., 2017; Horst et al., 
2018b). Administrating Ca (both orally and intravenously) successfully alleviated the 
magnitude of LPS-induced hypocalcemia (Figure 3A & B). Furthermore, utilizing a LPS-
eucalcemic clamp technique we determined that the total Ca deficit was ~27 g during an 
acute (12 hour) and intense model of immune activation (Horst et al., 2018b).  
  
Figure 3. Ionized Ca concentrations from cows allowed to develop hypocalcemia (solid 
line) vs. cows administered oral (A) or intravenous (B) Ca (dashed line) 
following lipopolysaccharide infusion. 
 
Although both models (oral and i.v. Ca) successfully lessened the degree of 
hypocalcemia, the impacts on productivity were markedly different. Administering oral Ca 
prior to and immediately following LPS administration improved milk yield and DMI when 
compared to cows allowed to become hypocalcemic (Al-Qaisi et al., 2017). In contrast, 
maintaining eucalcemia (via i.v. infusion) caused a more intense inflammatory response 
(i.e., increased acute phase proteins and rectal temperature) and impaired production 
performance (Horst et al., 2018b). Incidentally, LPS-induced severe hypocalcemia had 
no impact on neutrophil function nor did rescuing eucalcemia influence neutrophil function 
metrics (i.e., oxidative burst and myeloperoxidase activity; Horst et al., 2018b). Although 
it remains unclear why we observed conflicting results, it may be explained by the 
presence of both live yeast and Ca in the oral bolus. Yeast has previously been 
demonstrated to have immunomodulatory effects and benefit nutrient utilization, DMI, 
fermentation patterns, and lactation performance (Desnoyers et al., 2009; Broadway et 
al., 2015), therefore, we are unable to distinguish between the effects of live yeast vs. Ca 
in the oral bolus experiment. Another potential likely explanation for the conflicting results 
may be the route of administration. Intravenous Ca has recently been demonstrated to 
be detrimental to hormonal regulation of Ca when compared to oral boluses, and studies 
suggest it should not be utilized to treat subclinical cases (Wilms et al., 2019). 
Presumably, there are secondary signals associated with alimentary Ca absorption that 
might explain why the oral Ca improved multiple productivity metrics following 
immunoactivation and the i.v. route did not. 
 
 Even though the results of the eucalcemic-clamp trial (Horst et al., 2018b) were 
surprising, they actually agree with the sepsis literature. Septic humans are typically 
hypocalcemic (Zaloga, 1992; Kelly and Levine, 2013) and early reports indicate that Ca 
administration to septic patients increased the incidence of organ failure and mortality 
(Malcolm et al., 1989). It is now hypothesized that sepsis-induced hypocalcemia serves 
as a protective strategy and should not be considered pathologic. Early investigators 
described a critical role of decreased blood Ca for optimal LPS detoxification via non-
inflammatory routes (Figure 4; Skarnes and Chedid, 1964). In the absence of Ca, LPS 
aggregation is inhibited, a situation that allows LBP to transfer LPS monomers to cluster 
of differentiation 14 and eventually to acute-phase high density lipoproteins (ap-HDL) for 
biliary excretion. Formation of ap-HDL is mediated by SAA displacement of apolipoprotein 
from normal HDL (Skarnes and Chedid, 1964). This mechanism allows LPS to be 
detoxified with minimal leukocyte activation and thus less inflammation. In contrast, during 
eucalcemia the disaggregation of LPS monomers is inhibited (Skarnes and Chedid, 1964) 
and consequently, LPS is recognized by pro-inflammatory mechanisms; a scenario 
contributing to a hyper-inflammatory systemic response. Much remains unclear about 
why Ca decreases following immunoactivation, whether preventing it is beneficial, and 
where Ca is going during infection. These questions have direct implications to the 
periparturient inflamed dairy cow and to practical on-farm management and nutrition 
decisions. 
 
 
Figure 4. Calcium’s proposed role in LPS detoxification. 
Conclusion 
 
 Transient hypocalcemia remains a prevalent metabolic disorder afflicting dairy 
cows. Based upon the literature and our supporting evidence we suggest that SCH, along 
with the many disorders it is believed to be causal towards (i.e., ketosis, poor reproductive 
performance, metritis, etc.), can be explained (at least partially) by immune activation and 
the corresponding inflammatory response, a hypothesis which challenges several long 
standing dogmas in dairy science. More research is required to understand the 
mechanisms of infection induced-hypocalcemia and whether Ca administration (in 
particular the route of delivery) is beneficial or detrimental to SCH and future productivity.  
From a bigger picture perspective, we need a better understanding of whether or not 
these basic metabolites are “dangerous” (the reductionist theory) or are just reflective of 
prior immune insults. 
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